Mutant Fibulin-3 Causes Proteoglycan Accumulation and Impaired Diffusion Across Bruch's Membrane
Cross, Samuel D.
Stanton, James B.
Marmorstein, Alan D.
Marmorstein, Lihua Y.
AffiliationUniv Arizona, Dept Ophthalmol & Vis Sci
Keywordsage-related macular degeneration
MetadataShow full item record
PublisherASSOC RESEARCH VISION OPHTHALMOLOGY INC
CitationMutant Fibulin-3 Causes Proteoglycan Accumulation and Impaired Diffusion Across Bruch's Membrane 2017, 58 (7):3046 Investigative Opthalmology & Visual Science
RightsCopyright 2017 © The Authors. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
AbstractPURPOSE. The mutation R345W in EFEMP1 (fibulin-3) causes macular degeneration. This study sought to determine whether proteoglycan content and diffusion across Bruch's membrane are altered in Efemp1(ki/ki) mice carrying this mutation or in Efemp1(-/-) mice. METHODS. Proteoglycans in mouse Bruch's membranes were stained with Cupromeronic Blue (CB). Heparan sulfated proteoglycan (HSPG) and chondroitin/dermatan sulfate proteoglycan (C/DSPG) distributions were visualized following treatments with chondroitinase ABC (C-ABC) or nitrous acid. Total sulfated glycosaminoglycans (sGAGs) in Bruch's membrane/choroid (BrM/Ch) were measured with dimethylmethylene blue (DMMB). Matrix metalloprotease (MMP)-2, MMP-9, and tissue inhibitor of metalloproteinase (TIMP)-3 were examined by immunofluorescence and quantified using Image J. Molecules with different Stokes radius (R-s) were allowed simultaneously to diffuse through mouse BrM/Ch mounted in a modified Ussing chamber. Samples were quantified using gel exclusion chromatography. RESULTS. HSPGs and C/DSPGs were markedly increased in Efemp1(ki/ki) Bruch's membrane, and MMP-2 and MMP-9 were decreased, but TIMP-3 was increased. Diffusion across Efemp1(ki/ki) Bruch's membrane was impaired. In contrast, the proteoglycan amount in Efemp1(-/-) Bruch's membrane was not significantly different, but the size of proteoglycans was much larger. MMP-2, MMP-3, and TIMP-3 levels were similar to that of Efemp1(+/+) mice, but they were localized diffusely in retinal pigment epithelium (RPE) cells instead of Bruch's membrane. Diffusion across Efemp1(-/-) Bruch's membrane was enhanced. CONCLUSIONS. Mutant fibulin-3 causes proteoglycan accumulation, reduction of MMP-2 and MMP-9, but increase of TIMP-3, and impairs diffusion across Bruch's membrane. Fibulin-3 ablation results in altered sizes of proteoglycans, altered distributions of MMP-2, MMP-9, and TIMP-3, and enhances diffusion across Bruch's membrane.
NoteOpen Access Journal.
VersionFinal published version
SponsorsNational Institutes of Health [EY13847, EY13160, EY21153]; Edward N. & Della L. Thome Memorial Foundation; Mayo Foundation; Research to Prevent Blindness
- The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice.
- Authors: Fu L, Garland D, Yang Z, Shukla D, Rajendran A, Pearson E, Stone EM, Zhang K, Pierce EA
- Issue date: 2007 Oct 15
- [Proteoglycan in Bruch's membrane of senescence accelerated mouse: localization and age-related changes].
- Authors: Takada Y, Ohkuma H, Ogata N, Matsushima M, Sugasawa K, Uyama M
- Issue date: 1994 May
- Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration.
- Authors: Marmorstein LY, McLaughlin PJ, Peachey NS, Sasaki T, Marmorstein AD
- Issue date: 2007 Oct 15
- [Immunohistological study in Bruch's membrane of senescence accelerated mouse].
- Authors: Takada Y, Uyama M, Ohkuma H, Ogata N, Matsushima M, Deguchi J, Sugasawa K
- Issue date: 1994 Oct
- TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration.
- Authors: Kamei M, Hollyfield JG
- Issue date: 1999 Sep